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CONCISECOMMUNICATION

Borrelialonestart Infection after a Bite by an AmblyommaamericanumTick
1'a
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for InfectiousDiseases,Centersfor DiseaseControlandPrevention,
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and Molecular
of2Biochemistry
3
Biologyand Medicine,Divisionof InfectiousDiseases,
New YorkMedicalCollege,Valhalla

Erythematous rashes that are suggestive of early Lyme disease have been associated with
the bite of Amblyommaamericanumticks, particularly in the southern United States. However,
Borrelia burgdorferi, the causative agent of Lyme disease, has not been cultured from skin
biopsy specimens from these patients, and diagnostic serum antibodies usually have not been
found. Borrelia lonestari sp nov, an uncultured spirochete, has been detected in A. americanum
ticks by DNA amplification techniques, but its role in human illness is unknown. We observed
erythema migrans in a patient with an attached A. americanum tick. DNA amplification of
the flagellin geneflaB produced B. lonestari sequences from the skin of the patient that were
identical to those found in the attached tick. B. lonestari is a probable cause of erythema
migrans in humans.

Borrelia burgdorferi sensu stricto, which is transmitted by
ticks of the subgenus Ixodes, is the only established cause of
Lyme disease in North America [1]. In the United States, most
persons acquire Lyme disease in the northeastern or north central regions or in the Pacific Northwest; however, each year
hundreds of patients from southeastern and south central states
are reported to have this illness [2]. Several publications on
suspected Lyme disease in southern states describe patients with
a mild illness characterized by an erythema migrans rash that
develops at the site of a bite by Amblyomma americanum,the
lone star tick [3-6]. Despite the existence of B. burgdorferiin
enzootic cycles in southern states, human B. burgdorferiinfection acquired in this area has not been confirmed by culture
from clinical specimens. In addition, serologic tests rarely indicate exposure to this organism [3, 4, 6].
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A. americanum is the species of tick that most commonly
bites humans in the southeastern and south central United
States. It is distributed from central Texas and Oklahoma eastward across the southern states and along the Atlantic coast
as far north as Maine [7, 8]. In the laboratory, A. americanum
is an incompetent vector for B. burgdorferisensu stricto. Howof A.
ever, several studies have demonstrated that l07o-307o
americanum ticks are infected with a spirochete [9]. Although
this spirochete has not yet been cultured, phylogenetic analysis
of amplified DNA sequences has shown that it differs from all
borrelial species known to cause Lyme disease [9, 10]. Barbour
et al. [9] demonstrated by analysis of 16S rRNA sequences that
it is more closely related to the relapsing fever spirochetes Borrelia miyamotoi sp nov in Japan and to an unnamed Borrelia
species isolated from dogs in Florida. They proposed the name
Borrelia lonestari sp nov. Whether A. americanum ticks can
transmit B. lonestari to humans or whether B. lonestari causes
clinical illness has not been determined.
We describe a patient with erythema migrans at the site of
an attached lone star tick and at a secondary site, after recent
travel to Maryland and North Carolina. Clinical specimens and
the tick were evaluated for evidence of infection by Borrelia,
using polymerase chain reaction (PCR), culture, and serologic
tests.

Case Report
A 74-year-old African American man was evaluated on 24
May 1999 at New York Medical College (NYMC; Valhalla)
because of an abdominal skin rash that had been present for
~4 days, as well as fatigue, cough, and right shoulder discomfort of ~1 week's duration. He denied having fever or head-
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aches. The patient was a resident of southern Westchester
County, New York. He traveled to Maryland on 6 May and
then left Maryland on 6 May to travel to North Carolina, where
he stayed from 7 May to 18 May. He returned to Maryland
on 18 May and then left on 20 May to return to his home in
Westchester County. He had walked in grassy areas in both
Maryland and North Carolina. His medical history included a
left nephrectomy in June 1998 for a renal cell carcinoma, prostate carcinoma diagnosed in 1997, colonic carcinoma resected
in 1985, hypertension, and hypothyroidism.
At examination, the patient had an oral temperature of
36.80C. Results of musculoskeletal, neurologic, pulmonary, and
cardiac examinations were normal. A 19 X 11-cm annular erythematous lesion surrounding an attached, engorged tick was
present in the right lower quadrant of the abdomen, and a
separate 4 X 3-cm erythematous lesion was present in the left
upper quadrant (figure \A, \B). The patient first noticed the
tick on 15 May but did not remove it because he thought it
was a skin lesion. The tick was removed at NYMC on 24 May
for taxonomic evaluation and microbiologic studies.
Laboratory evaluation showed normal white blood cell count
and differential, hemoglobin level, and platelet count. Results of
analysis of serum chemistry were normal, except for an alkaline
phosphatase level of 142 U/L (normal range, 35-110 U/L). An
electrocardiogramshowed premature atrial contractions.
Beginning 24 May, the patient received a 14-day course of
doxycycline (100 mg orally twice daily). The skin lesions resolved by 4 June. The patient reported that he had returned to
his usual state of health by 16 June 1999.

Materials and Methods
Skin biopsy and culture. On 24 May 1999, a 2-mm punch
biopsy sample was taken from the edge of the skin lesion in the
right lower quadrantof the abdomen, farthestfrom the site of tick
attachment.The skin samplewas processedat NYMC for B. burgdorfericulture and PCR studies, as reportedelsewhere[11].
Tick methods. The removed tick was identifiedas a female of
the species A. americanumand was sent to the Centersfor Disease
Control and Prevention(CDC) at Fort Collins, Colorado, for further study.At the CDC, the tick was cut in half longitudinally.One
half was processedfor PCR, as describedbelow, and the other half
was processedfor coculturewith Ixodes scapularisembryoniccells
(cell line IDE2; a gift from T. Kurtii, University of Minnesota,
Minneapolis). The coculture was preparedas describedby Kurtii
et al. [12], was incubated at 3rC, and was checked by dark-field
microscopyeveryweek for 2 months for the presenceof spirochetes.
PCR. DNA from the skin specimen and the patient's blood
was extractedat NYMC by using an IsoQuicknucleicacidisolation
kit (Orca Research). Because the skin specimen had been transported from the clinic in BSK-H medium (Sigma), DNA was prepared from both the skin itself and the medium fraction ("supernatant"). At the CDC, DNA from the tick was prepared by
maceration of the tick in 1 mL of a guanidiniumreagent (DNA
STAT-60;Tel-Test) and was isolated according to the manufac-
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turer's instructions.DNA samples from the patient's skin biopsy
specimen, skin supernatant, and blood and from the tick were
exchanged between the NYMC and CDC laboratories,and PCR
was done at each site.
Nested PCR amplificationwith broadly-reactiveflagellin gene
(flaB) primerswas done at NYMC and the CDC by using primers
FlaLL and FlaRL in the first amplificationand primersFlaLS and
FlaRS in the second amplification,after the amplicons in the first
product were diluted 1:100 with water. Primers, reaction conditions, and thermal cycling were as describedelsewhere[9]. Specimens also were tested for the presenceof B. burgdorferiDNA by
PCR, with species-specificprimersdirected at the 23S rDNA duplication [11],the 16S-23SrDNA spacer,and ospA [I]. In addition,
amplificationof the 16S rDNA sequencewas done by using broadrangeeubacterialprimers[13]and primersbased on the B. lonestari
16S rDNA sequence [9].
DNA sequencing. The PCR products obtained in each laboratory from the skin-samplesupernatantand the A. americanum
tick were sequenced at the CDC after purificationwith a Qiagen
PCR kit. Sequencingwas done using a Taq DyeDeoxy terminator
cycle-sequencingkit (Applied Biosystems)and was run on an Applied Biosystems Model 373A automated sequencer. Sequences
were obtained from both DNA strands for each sample. The B.
lonestariflaB sequences from skin and tick DNA have been deposited in GenBank (accession nos. AF273670 and AF273671).
Serologictests. Serumsamplesobtained from the patientduring the acute (24 May) and convalescent (2 and 26 June) phases
of illness were tested for antibodies to B. burgdorferiby an IgG/
IgM ELISA (WampoleLaboratories).IgM and IgG antibodiesto
B. burgdorferiwere measuredseparatelyby immunoblotting,using
serum diluted 1:100. The B. burgdorferiantigens were from strain
B31 (low passage;CDC referencecollection) grown in BSK-H medium and were fractionated(15 /ngper minigel) by discontinuous
SDS-PAGE through 13.50Zo
acrylamidegels; immunoblottingwas
done by standardprocedures[1].

Results
No laboratory evidence of B. burgdorferiinfection was found.
Culture of the skin biopsy sample in BSK-H medium and coculture of the sample of tick cells failed to propagate B. burgdorferi. Moreover, B. burgdorferisequences were not detected
by PCR of DNA prepared from skin, skin supernatant, or
blood, using 3 different sets of B. burgdorferi-spGcificprimers.
Acute- and convalescent-phase serum samples were negative
for B. burgdorferi antibody by ELISA and immunoblotting.
No IgM bands were found to be present on immunoblots for
B. burgdorferiantigen; only a single IgG band at the position
of FlaB, a 41-kDa antigen, was detected in both the acute- and
convalescent-phase serum samples (data not shown).
In contrast, DNA evidence compatible with B. lonestari infection was obtained. Amplification of the flaB, using Borrelia
genus-wide PCR primers, resulted in products of ~350 bp from
both the patient (DNA from the supernatant of the skin sample)
and the tick, at both the NYMC and the CDC (figure 2A).
The positive control (figure 2A) was B. burgdorferiDNA from

tick. A, Skin lesion with central
Figure 1. Erythemamigransof case patientand point of attachmentof femaleAmblyommaamericanum
clearing,in rightlower quadrantof abdomen.Raisedlesion marksindicatefromwhich area the attachedtick was removed.B, Skin lesion in
left upperquadrantof abdomen,below surgicalscar.
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Figure 2. Analysis of DNA from case patient and tick. A, flaB DNA amplified by polymerase chain reaction (PCR). Amplicons were separated
by electrophoresis on a 1%agarose gel and were detected by ethidium-bromide staining. Lane M, Molecular weight markers, in 100-bp intervals;
lane 1, negative control (water); lane 2, case patient DNA from supernatant of a skin biopsy sample; lane 3, tick DNA; lane 4, positive control
(Borrelia burgdorferiB31 DNA). B, Deduced amino acid sequence of portion of flaB DNA amplified from both patient skin-sample supernatant
and the attached tick. Sequences are compared with the equivalent regions of flaB from B. lonestari in ticks from New Jersey, B. miyamotoi HT31,
and B. burgdorferiB31. GenBank accession nos. for the reference sequences are AAA99141, BAA07832, and CAA33696, respectively. *Amino
acid position that showed sequence heterogeneity in the uncloned amplicons. Serine was deduced from the AGT sequence of tick DNA amplified
at both New York Medical College (NYMC; Valhalla) and the Centers for Disease Control and Prevention (CDC; Fort Collins, Colorado) and
from patient skin-sample supernatant DNA amplified at NYMC. Threonine was deduced from the ACT sequence of skin-sample supernatant
DNA amplified at the CDC. Nos. correspond to the amino acid positions of FlaB in B. miyamotoi.

cultured spirochetes, not from skin. During 1991-1997, we detected B. burgdorferiDNA in 65% (192 of 294) of skin biopsy
specimens from patients with erythema migrans. It was not
uncommon for B. burgdorferiDNA to be detected in a skinsample supernatant but not in the corresponding macerated
skin extract (I.S., unpublished data). No amplicons were detected with DNA produced from the macerated skin sample,
from the patient's blood, or from the negative controls that
lacked DNA.
Sequencing of 4 PCR products, from amplicons produced
independently in each laboratory from DNA of the skin-sample
supernatant and of the tick, revealed that this portion offlaB
was identical in host and vector samples, with the possible
exception of the amino acid marked by an asterisk in figure
2B. Sequences differed only slightly from those obtained elsewhere for B. lonestari in A. americanumticks from New Jersey
and Texas [9]. All sequences in this study contained an extra
AGA at positions 330-332, compared with the published B.
lonestari sequences (GenBank U26704-5) and 2 nucleotide differences near the 3' end of the amplicons. The deduced amino

acid sequence contains an extra glutamic acid as a consequence
of the AGA insertion at amino acid position 211 (figure 2B).
In this study, we found 2 conservative amino acid changes near
the carboxy terminus, an isoleucine followed by serine, compared with valine-threonine in the B. lonestari sequences in ticks
from New Jersey. Alignment of the deduced amino acid sequences obtained from the skin biopsy sample and the tick with
the equivalent regions of FlaB from other Borrelia species confirms that the sequence does not differ significantly from the
B. lonestari sequence (figure 2B).
Discussion
The clinical and laboratory data from this study strongly
suggest that A. americanum ticks transmit B. lonestari to humans and cause an illness that is indistinguishable clinically
from early stage Lyme disease. First, there was a temporal
relationship between the bite of an A. americanum tick and
erythema migrans at the site of the tick bite and at a remote
region. Second, we identified B. lonestariflaB sequences in both
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the tick and a skin sample obtained from the periphery of the
skin lesion. Third, laboratory evidence (culture, PCR, and serologic tests) does not support a diagnosis of infection by B.
burgdorferi, although the skin lesion resolved after standard
antibiotic therapy for Lyme disease.
Curiously, our repeated attempts to amplify 16S rDNA fragments both from the biopsy specimen and from the tick extract,
using broad-range eubacterial and B. lonestari-spQcificprimers,
were unsuccessful. The reason for this failure is unclear, although the relatively larger PCR product expected from such
amplification (~1400 bp vs. 350 bp) and a low number of Borrelia genome equivalents in the samples may account for this
observation.
The validity of using flaB sequences to establish Borrelia
taxonomy has been demonstrated elsewhere [14]. Furthermore,
in numerous instances, sequence-based identification of a microbe that had not been cultured provided the initial evidence
for disease causation. Another tickborne illness, human monocytic ehrlichiosis, is a pertinent example [15]. The seminal observations from gene sequencing of Ehrlichia chaffeensis provided the impetus for the eventual development of culture
methods and specific serum antibody tests.
An important question is how many of the other reported
cases of erythema migrans or erythema migrans-like illness in
southern states and elsewhere in the United States are due to
B. lonestari. A Lyme disease-like illness after a bite from an
A. americanumtick has been reported in New Jersey [8]. Of 3
series of patients with an illness involving a rash who were from
the southern United States, 9Vo-\4Vorecalled a preceding tick
bite that was consistent with that of A. americanumticks [3, 4,
6]. Because only adult female A. americanumticks are likely to
be identified by patients, these proportions should be regarded
as minimum estimates. Masters et al. [5] have described 17
selected patients with erythema migrans-like illness who were
from Missouri, all of whom had a preceding bite from an A.
americanumtick. Theoretically, B. lonestari-infGCtedA. ameriI. scapucanum may be sympatric with B. burgdorferi-infQctQd
laris, particularly in states along the eastern seaboard. This
coexistence has been documented in New Jersey [2,8]. In such
areas, 2 different Borrelia species may cause erythema migrans,
and not all erythema migrans will indicate Lyme disease.
A specific serologic test for evidence of exposure to B. lonestari
is not yet available. We are working to develop and validate such
a test, because it will be an important tool in determining the
etiology of erythema migrans in individual patients and in understanding the epidemiology of B. lonestari infections.
In the United States, B. lonestari may be a new tickborne
pathogen of humans. This case report suggests that efforts to
assess the public health importance of B. lonestari infection are
warranted. This assessment should include concerted clinical
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and epidemiologic studies and field investigations of vector ticks
and their hosts.
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